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ABSTRACT 
Approximately 400 million people worldwide suffer from bladder disease, which 
can lead to the development of high pressure and low-compliance bladders.  Current 
surgical solutions include replacing diseased bladder tissue with a segment of 
gastrointestinal (GI) tissue, referred to as a bladder augmentation.  However, GI segments 
are known to cause a myriad of issues when implanted within the bladder, including 
urinary tract infection, metabolic abnormalities and abnormal drug kinetics. The objective 
of the present study is to investigate hADSCs as a cell source to seed a biomimetic 
bladder tissue patch for the purpose of bladder tissue remodeling and regeneration. 
hADSCs were exposed to smooth muscle inductive medium (SMIM) to induce smooth 
muscle cell (SMC) differentiation.  Differentiated SMCs and urothelial cells were also 
cultured in non-inductive growth media to determine the level of differentiation. Changes 
at the morphological, mRNA and protein level were observed through phase-contrast 
imaging, RT-PCR and immunofluorescence.  Differentiated SMCs and urothelial cells 
were co-cultured in varying media conditions to determine the effect of each cell type on 
the retention of the other’s differentiated traits, and changes at the protein level were 
observed.  Differentiated SMCs were also cultured on fibronectin-gelatin coated PCUU 
scaffolds to determine the SMCs ability to infiltrate the scaffold.  After culture in SMIM 
for 10 days, ADSCs exhibited increased mRNA expression of αSMA, SM-22α and SM-
MHC and decreased expression of CD90 and CD105.  Protein expression of αSMA, SM-
22α and SM-MHC was also exhibited after incubation in SMIM.  Culture in non-
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inductive media led to the decrease in mRNA expression of  α-SMA, SM-22α and SM-
MHC and UP1b in SMCs and urothelial cells, respectively, while CK20 remained 
unchanged.  mRNA expression of CD90 and CD105 was increased after incubation in 
non-inductive media in both dedifferentiated SMCs and urothelial cells.  At the protein 
level, expression of SM-MHC and UP1b was lost in dedifferentiated SMCs and urothelial 
cells, respectively, while expression of α-SMA, SM-22α and CK20 was retained.  After 
incubation in a co-culture, protein expression of SM-MHC and UP1b was lost in SMCs 
and urothelial cells, respectively, while expression of α-SMA, SM-22α and CK20 was 
retained. Differentiated SMCs seeded onto a coated PCUU scaffold infiltrated the 
scaffold to a greater degree than SMCs seeded onto an uncoated scaffold.  Results of the 
present study indicate that soluble factors present in the cellular microenvironment have a 
pronounced effect on differentiation. In the present study, culturing ADSCs in SMIM was 
proven to be an effective method in differentiating toward a SMC lineage. However, 
differentiated SMCs and urothelial cells dedifferentiated once factors important to 
differentiation were removed.   Co-culturing of differentiated SMCs and urothelial cells 
did not support retention of differentiated traits either. Taken together, these in vitro 
results indicate that cells differentiated via soluble factors within the media only achieve 
partial differentiation.  When the differentiated SMCs were seeded on a PCUU scaffold, 
layer-by-layer coating with fibronectin and gelatin enhanced the infiltration into the 
scaffold.  This is likely due to the adsorption of fibronectin to the scaffold and subsequent 
interaction with gelatin provides cellular adhesion sites both within and on the surface of 
the scaffold.   
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Chapter 1: Introduction and Background 
1.1 Urinary Bladder 
The urinary bladder is a visceral organ responsible for the storage and voiding of 
urine.  The organ can become diseased and undergo damage from a variety of medical 
conditions, which can reduce its functionality.  Tissue engineering of the urinary bladder 
aims to regenerate a diseased urinary bladder to full functionality through the use of 
tissue scaffolds and cellular material.  Currently, researchers are developing novel 
methods of bladder tissue regeneration using scaffolds seeded with cells to aid and 
accelerate the tissue healing process. 
1.1.1 Bladder Anatomy and Physiology 
The urinary bladder is a hollow organ that is composed of two main parts:  the 
body and the neck.  The overall function of the bladder is the temporary storage and 
periodic voiding of urine.  To properly perform these functions, the bladder must be able 
to expand and contract, while maintaining a low internal pressure.  The capacity of a 
normal bladder is 400-500 mL and the normal range of bladder intravesical pressure is 5-
50 cm H2O, depending on the position of the body (Tanango and McAninch, 2008).  The 
bladder is primarily made up of three layers: detrusor (smooth muscle), stroma, also 
known as the lamina propria, and transitional epithelium and is illustrated in Figure 1. 
The transitional epithelium, or urothelium, is composed of urothelial cells lining 
the inside of the bladder, which are joined by tight junctions.  The main role of the 
urothelium is to contain the urine within the bladder, and disallow the interaction of urine 
with other parts of the body. These cells are characterized by the protein groups 
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uroplakins and cytokeratins, specifically uroplakin-1b (UP1b), and cytokeratin-20 
(CK20).    Other examples of uroplakins and cytokeratins include UP1a, UPII, UPIII, 
cytokeratin-5, -7, -8,- 9, -14, -17, -18 and -19 (Khandelwal, 2009). Cytokeratins are 
keratin containing intermediate filaments found in the intracytoplasmic cytoskeleton of 
epithelial tissue (Veranic et al, 2006).  They contribute to urothelial cells’ large elastic 
modulus and to the protection of the bladder against mechanical stress.  Different types of 
cytokeratins are expressed in the different layers of urothelium.  For example, 
cytokeratin-13 is expressed by intermediate and basal urothelial cells, CK-5, -14 and -17 
are expressed by only basal cells and CK-20 is solely expressed in superficial, umbrella 
cells (Veranic, 2006; Khandelwal, 2009).  Uroplakins are located mainly on the 
superficial and upper intermediate cell surface.  They are categorized as an asymmetric 
unit membrane (AUM) particle, and further grouped as transmembrane proteins.  These 
types of proteins contribute to the impermeability of the urothelium (Khandelwal, 2009) 
The stroma is made up of myofibroblasts, collagen and elastin.  Collagen gives 
the bladder structural support while elastin allows for it to be highly compliant and gives 
it the ability to expand to great volumes.  The myofibroblasts within the stroma have been 
reported to, under certain conditions, differentiate into new smooth muscle cells to aid in 
bladder repair (DeLancey, 2002).  The main function of the stroma is to provide support 
and compliance for the other layers of the bladder.   
The detrusor layer is made up of smooth muscle cells (SMCs) and functions in 
much the same way as other muscle groups within the body; contraction is caused by an 
interaction between thin and thick filaments.  However, contractions of the detrusor 
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muscle are more phasic in nature when compared to any other smooth muscles 
(DeLancey, 2002).  The main role of the detrusor muscle is to “maintain the integrity of 
the bladder without generating significant intravesical pressure during filling, and to 
contract synchronously to elevate intravesical pressure sufficiently and for long enough 
to empty the bladder” (DeLancey, 2002).  The SMCs that make up the detrusor muscle of 
the bladder are characterized by the proteins α-smooth muscle actin (α-SMA), smooth 
muscle-22α (SM-22α) and smooth muscle-myosin heavy chain (SM-MHC), among 
others.  α-SMA and SM-22α are contractile proteins found in SMCs (Wang et al, 2010; 
Harris et al, 2011).  However, α-SMA is a widely conserved protein within many cell 
types and is not specific to a smooth muscle lineage. SM-22α is also a conserved protein 
shown to be specifically transcribed in two cell types: SMCs and pluripotent stem cells, 
specifically adipose derived stem cells (Harris et al, 2011).  SM-MHC is also a 
contraction protein found in SMCs and is highly restricted to differentiated smooth 
muscle and is indicative of a fully differentiated SMC (de Villiers et al, 2009).   
All the layers of the bladder work together to store and release urine during a 
process known as micturition.  The micturition process has two main phases, the storage 
phase and the voiding phase.  During storage, urine fills the bladder cavity and the organ 
expands to keep the intravesical pressure low.  During voiding, a voluntary signal is sent 
from the brain to nerves within the bladder that stimulates the detrusor muscle to 
contract.  This increases the pressure within the bladder and leads to urine flowing 
through the urethra and exiting the bladder. 
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1.1.2 Bladder Pathology 
Approximately 400 million people worldwide suffer from bladder disease 
including congenital malformations, bladder cancers and voiding dysfunctions 
(Oberpenning et al, 1999; Bouhout et al, 2013; Tran and Damaser, 2015; NYU School of 
Medicine).  All of which can lead to patients developing high pressure and hypertonic 
low compliance bladders, which can increase the risk of acute kidney failure and 
subsequent renal damage  (Atala et al, 2006).  
1.1.2.1 Congenital Malformations 
Congenital malformations of the bladder are anomalies in the anatomy or 
physiology of the bladder that are present at birth.  Exstrophy is an example of a 
congenital malformation.  It involves a “failure of midline closure from the umbilicus to 
Figure 1. Anatomy of the bladder wall. 
(Bergman et al, 2015)  
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the perineum, resulting in bladder mucosa continuity with the abdominal skin” (Merck 
Manuals).  This results in urine dripping from the open bladder, rather than flowing 
through the urethra. 
1.1.2.2 Bladder Cancer 
About 74,000 people are diagnosed with bladder cancer each year and the most 
common type is transitional cell carcinoma (American Cancer Society).   This type of 
cancer starts within the urothelium of the bladder, as most bladder cancers do.  
Transitional cell carcinoma results in tumor growth and weakening of the bladder wall. 
1.1.2.3 Voiding Dysfunction 
Voiding dysfunction is an abnormality of the filling and/or emptying of the 
bladder.  It can be caused by inappropriate muscle activity of the bladder wall or pelvic 
floor that may deter the starting and stoppage of urine flow (NYU School of Medicine).  
Neurological damage may also contribute to voiding dysfunction as well as some 
medications.  This medical condition encompasses neurogenic bladder, stress urinary 
incontinence and overactive bladder. 
Neurogenic bladder is caused by a number of conditions including trauma, 
Parkinson’s disease and multiple sclerosis (Cleveland Clinic). These injuries and diseases 
result in an interruption in communication between the nerves in the spinal cord that 
control bladder function (Mayoclinic).  This results in urgency, an inability to urinate, 
and frequent or painful urination. 
Stress urinary incontinence (SUI) is the involuntary leakage of urine during 
events that cause increased abdominal pressure in the absence of bladder contraction 
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(Tran & Damaser, 2015).  This is a prevalent condition affecting almost one in five adult 
women and half of all incontinent women (Nikolopoulos et al, 2015).  SUI results from 
an anatomical defect in the endopelvic fascial layer weakening of pelvic floor muscles 
and failure of the urethral sphincter (Pate et al, 2007; Wood and Anger, 2014; Tran and 
Damaser, 2015). 
 Overactive bladder (OAB) affects up to 16% of men and women in the United 
States (Stewart et al, 2003).  OAB is characterized by urgency usually accompanied with 
frequency of urination and nocturia in the absence of infection or other pathology, and 
may be associated with detrusor over activity (Tran and Damaser, 2015).  In OAB, 
detrusor over activity may result from “increased cellular excitability of the detrusor 
muscle and/or abnormal neural propagation locally as well as altered peripheral afferent 
nerve and central nervous system function” (Tran & Damaser, 2015). 
1.1.3 Current Treatment for Bladder Pathologies 
Bladder pathologies, such as neurogenic bladder, congenital malformations and 
bladder cancer are often treated by replacing diseased tissue with gastrointestinal (GI) 
segments for tissue repair and replacement, technically referred to as a bladder 
augmentation.  However, GI segments are known to cause a myriad of issues when 
implanted within the bladder including: urinary tract infection, metabolic abnormalities, 
abnormal drug kinetics, secondary malignancies, impaired renal function and donor site 
morbidity (Tu et al, 2013; Vasdev et al, 2013).  These problems are often due to the fact 
that GI tissues naturally absorb specific solutes that bladder tissue is designed to excrete 
(Atala, 2011). 
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Experiments involving cell-seeded tissue-engineered bladder composites have 
been underway since 1992, and traditionally involve a surgical harvest of a portion of a 
patient’s bladder to obtain primary bladder SMC’s (Jack et al, 2009).  These primary 
cells were then cultured for 6-8 weeks in a laboratory setting to obtain a cell mass large 
enough to seed a scaffold.  However, there is a lack of viable, accessible cells within 
malignant and pathological bladders.  There are still concerns when harvesting primary 
cells from non-pathologic bladders; investigators have found transmission of neuropathic 
cells from neuropathic bladders into the tissue-engineered bladder (Jack et al, 2009). 
Given the lack of healthy primary cells to infiltrate a tissue-engineered scaffold, 
other cell sources must be researched.  Alternative cell types can include induced 
pluripotent stem cells, embryonic stem cells, placental stem cells and adult stem cells 
such as adipose derived stem cells and bone marrow mesenchymal stem cells.  These 
types of cells are guaranteed to be healthy and viable, and can differentiate into a 
multitude of cell lines, which can then be used for a number of tissue engineering 
applications. 
1.1.4 Market Pull for Tissue Engineering of Human Bladder 
On average, 20,000 bladder augmentations are performed each year, and each 
procedure costs about $15,000 USD (BioPlan Associates, 2001; Sahai, 2014).  Therefore, 
the overall market for bladder augmentations is 300 million dollars per year. Due to GI 
tissues’ inability to create a fully functional and integratable organ substitute, there exists 
a need for an innovative replacement tissue that performs the same function as urinary 
bladder tissue but does not generate an array of medical complications.  Once this novel 
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product has been developed, it will have the opportunity to revolutionize the bladder 
reconstruction industry and envelope the market for this procedure. 
1.2 Bladder Tissue Engineering Scaffolds 
The regeneration of the urinary bladder via a tissue engineering approach often 
involves the use of scaffolds for cells.  These scaffolds aid in regeneration by acting as 
the framework on which new tissue can develop and grow.  Complete and functional 
repopulation of all bladder components is required in the excised area that has been 
replaced by the biomimetic scaffold (Figure 2; Lin et al, 2015).  Scaffolds can also 
deliver soluble factors and be seeded with cells that aid in the regeneration process.  
Tissue engineering scaffolds used in bladder reconstruction and regeneration include 
naturally derived acellular, acellular synthetic and cell-seeded scaffolds (Mahfouz et al, 
2013). 
1.2.1. Naturally Derived, Acellular Scaffolds 
Naturally derived, acellular scaffolds have been harvested from the body of a 
human or animal and are subjected to decellularization to remove cellular debris.  
Common naturally derived scaffolds for bladder tissue engineering include bladder 
Figure 2. Bladder Reconstruction. Reconstruction of a bladder is shown utilizing a 
biomimetic scaffold for full regeneration (Lin et al, 2015) 
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allografts, dura, placenta, pericardium and small intestine submucosa (Pattison et al, 
2004).  These scaffolds are advantageous because they offer the ideal mechanical and 
biomechanical environment for tissue regeneration (Bouhout et al, 2013).  Bladder 
acellular matrices (BAMs) are especially advantageous because they resist graft 
shrinkage and have shown positive results in respect to cellular repopulation (Brown et 
al, 2002).  Specifically, BAMs have been shown to promote the ingrowth of urothelium, 
smooth muscle and blood vessels (Brown et al, 2002).  Small intestine submucosa (SIS) 
has also been shown to regenerate a variety of host tissues including blood vessels, 
urothelium and neophyte muscle tissue (Yoo et al, 2011).  However, SIS has also shown 
a significant decrease in the muscle to collagen ratio, and a significant decrease in 
maximum contraction once implanted (Yoo et al, 2011).  The decellularization process of 
these naturally derived scaffolds can denature the extracellular matrix proteins and alter 
the physiological environment resulting in mechanical failure and poor biocompatibility 
properties.  Other drawbacks to naturally occurring scaffolds include limited availability 
of donor tissue, ethical issues and the possible transfer of diseases from donor tissues 
(Pattison et al, 2004). Therefore, the use of synthetic materials for bladder regeneration 
and reconstruction has become the focus and material of choice for recent studies. 
1.2.2 Acellular Synthetic Scaffolds 
Acellular synthetic scaffolds are created through the use of polymers such as 
poly-lactic-glycolic acid (PLGA), polyglycolic acid (PGA) and silk fibroin (Tu et al, 
2013; Atala et al, 2006; Lai et al, 2005).  These synthetic polymers, and their degradation 
products, have been shown to induce a minimal inflammatory response.  Synthetic 
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scaffolds are advantageous due to the ability to finely tune the physical properties of the 
polymers such as degradation, mechanical strength and pore size.  However, these 
scaffolds often result in poor vascularization and cellular infiltration, calcification and 
urinary stone formation once implanted within the body (Bouhout et al, 2013; Pattison et 
al, 2004).  Although there are some drawbacks to the use of synthetic scaffolds, polymers 
are considered by many to be the future of urologic replacement materials due to their 
numerous advantages, such as superior biocompatibility, biodegrability, ease of 
procurement and ease of modification over naturally occurring scaffolds (Pattison et al, 
2004).  The most common types of synthetic scaffolds used in bladder tissue engineering 
are those that are produced through electrospinning. 
1.2.3 Cell Seeded Scaffolds 
Both naturally derived and synthetic scaffolds may be seeded with cells to aid in 
the regeneration of bladder tissue.  Cells can be harvested from many different sources 
and used in tissue engineering for tissue regeneration and repair.  The two main cell 
sources used in bladder tissue engineering include differentiated autologous cells and 
stem cells. 
1.3 Cell Types Used in Tissue Engineering Applications 
Cells used in tissue engineering applications are present to enhance the efficacy 
and rate in the regeneration of tissue.  The cells used to infiltrate a scaffold can be either 
autologous differentiated cells, or autologous stem cells.  Autologous differentiated cells 
are harvested from the bladder, and autologous stem cells can be harvested from multiple 
areas including adipose tissue, amniotic fluid and bone marrow. 
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1.3.1 Differentiated Autologous Cells 
Primarily, differentiated autologous cells are unipotent, urothelial cells and 
smooth muscle cells that have been harvested from the patient to be used for scaffold-
seeding purposes. However, major concerns have become apparent from using 
autologous cells.  If the cells are to be harvested from a diseased organ, there may not be 
enough normal and healthy cells in the organ to be obtained for expansion (Mahfouz et 
al, 2013).  In addition, it is difficult to conclude if the underlying disease has altered 
healthy cells within the organ.  The process of harvesting autologous cells and expanding 
them to a population large enough to seed a scaffold is also often extremely lengthy. It 
can require up to six weeks to expand the autologous cells to acquire the necessary 
number to seed the scaffold.   
1.3.2 Stem Cells 
Unlike differentiated cells, stem cells have the following set of distinct 
characteristics: unlimited self-renewal, replication in an undifferentiated state, the ability 
to differentiate into other cell types, specialization of cells and acquisition of function.  
Stem cells can be categorized into 5 subsets depending on their function.  Totipotent stem 
cells can give to any type of cell within the human body.  Pluripotent stem cells can give 
rise to any type of cell in the human body except for gametes.  Multipotent stem cells can 
differentiate into most cell types within the body, but not all.  Oligopotent stem cells can 
give rise to a few cell types in the body.  Finally, unipotent stem cells can only be 
differentiated into one cell type.  Stem cells are especially useful for researchers because 
they can be infinitely expanded in the laboratory while still maintaining their 
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pluripotency.  Different types of stem cells used in bladder tissue engineering include, but 
are not limited to, induced pluripotent stem cells, embryonic stem cells, amniotic fluid 
stem cells and adult stem cells. 
1.3.2.1 Induced Pluripotent Stem Cells 
Induced pluripotent stem cells (iPS cells) are a unique population of stem cells 
recently discovered by Takahashi and Yamanaka.  Differentiated cells are reprogrammed 
into an embryonic-like state by the transfer of nuclear contents or by fusion with 
embryonic stem cells (Takahashi & Yamanaka, 2006).  These cells have been 
demonstrated to exhibit multi-potency and self-renewal and can be used autologously 
(Tran & Damaser, 2015).  However, it often takes a substantial amount of time to 
reprogram differentiated cells, which is then followed by a period of time to allow for 
differentiation.  
1.3.2.2 Embryonic Stem Cells 
Embryonic stem cells (ES cells) are pluripotent and an ideal cell source for tissue 
engineering.  However, complications often arise from the use of this cell type due to 
their proclivity to from teratomas, the topic of ethics, and the fact that these cells are not 
autologous which can lead to antigenicity (Mahfouz et al, 2013).  Therefore, these cells 
are not frequently used for seeding scaffolds in bladder reconstruction. 
1.3.2.3 Amniotic Fluid or Placental Stem Cells 
Amniotic fluid or placental stem cells (AFPS cells) exhibit properties intermediate 
to those of embryonic stem cells and adult stem cells.  The population of cells found 
within the amniotic fluid and placenta include mesenchymal stem cells and multipotent 
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AFPS cells (Tran & Damaser, 2015).  AFPS cells can be induced to differentiate into 
cells of all three germ layers including cells of adipogenic, osteogenic, myogenic, 
endothelial, neural, and hepatic lineages (Tran and Damaser, 2015).   
1.3.2.4 Adult Stem Cells 
 Adult stem cells are undifferentiated cells that can be harvested from various 
areas of the human body, including adipose tissue and the bone marrow, and at various 
time points during maturation.  These cells are pluripotent and can give rise to a number 
of cell types through differentiation.  The different types of adult stem cells used in 
bladder tissue engineering include bone marrow mesenchymal stem cells and adipose 
derived stem cells. 
 Bone marrow mesenchymal stem cells (BM-MSC) are advantageous to bladder 
tissue engineering as they can be directly differentiated into SMCs (Mahfouz et al, 2013).  
They also “secrete a variety of pro-angiogenic, pro-regenerative and mitogenic cytokines 
that favor regeneration” (Mahfouz et al, 2013).  However, BM-MSC’s are rare, and 
harvesting large quantities of the bone marrow poses a significant risk to the patient (Kim 
et al, 2014).  BM-MSC’s also require a long expansion time and a complicated isolation 
procedure (Kim et al, 2014).  Therefore, BM-MSC’s are not an ideal candidate to be used 
in bladder tissue engineering. 
 Adipose derived stem cells (ADSC) derive from the mesoderm that reside within 
adipose tissue in the human body and have the potential to differentiate into all three 
germ layers (Mahfouz et al, 2013).  The primitive nature of ADSCs allows them to be 
differentiated into a number of cell lineages including adipogenic, epithelial, bone, 
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muscle, cartilage and neuronal (de Villiers et al, 2009).  Unlike bone marrow 
mesenchymal stem cells, adipose tissues are easily harvested from the body during 
liposuction and ADSCs are then easily isolated (Jack et al, 2009).  ADSCs are easy to 
handle and exhibit great proliferative capacity (de Villiers et al, 2009).  Donated 
allogeneic ADSCs also show a very low antigenicity, with no expression of 
immunologically relevant surface antigens both in a non-differentiated and differentiated 
state (Niemeyer et al, 2007).  Therefore, autologous ADSC’s are an ideal candidate for 
regenerative medicine, specifically bladder regeneration and reconstruction. 
1.4 Differentiation Techniques 
Stem cells may be differentiated into a terminal cell lineage prior to seeding on a 
scaffold for tissue regeneration purposes.  Timely cell proliferation and native tissue 
development from stem cells will facilitate overall regeneration and recovery time.  The 
differentiation technique varies depending on cell lineages of interest and investigators.  
1.4.1 Conditioned Media 
Conditioned media is obtained from culturing terminally differentiated cells in 
growth media, and then adding that growth media to stem cell cultures to induce 
differentiation (Figure 2).  This method of differentiation has been used to successfully 
differentiate stem cells into a number of cell lineages including urothelium, acinar cells 
and SMCs (Tiang et al, 2010; Zhang et al, 2014; Lee et al, 2015).  Cytokines and other 
compounds that are secreted into the conditioned media by the terminally differentiated 
cells presumably induce stem cell differentiation.  In a study by Zhang et al, the 
cytokines responsible for differentiation of ADSC’s into urothelial cells were determined 
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to include TGF-α, PDGF-BB, VEGF, IGF-I and EGF among others (Zhang et al, 2014).  
However, one drawback to this methodology is the requirement of a terminally 
differentiated cell population.  To apply this to bladder regeneration, autologous 
urothelial and smooth muscle cells would be needed.  Healthy autologous cells would be 
few in the patient’s diseased bladder, rendering this option less attractive. 
1.4.2 Soluble Factors 
 The methodology of differentiating stem cells via incorporating exogenous 
soluble cytokines and growth factors in culture media (Figure 2) has been proven 
effective for differentiation of ADSCs into SMCs, urothelium, nervous tissue and 
cartilage (Faroni et al, 2013; Stromps et al, 2014; Wang et al, 2010; Harris et al, 2011) 
(Table 1). The exact mechanism by which differentiation is achieved through soluble 
factors is unknown; however, it is hypothesized that paracrine and autocrine signaling is 
of upmost importance. The factors mechanically introduced into the media are thought to 
be the same as the cytokines released by cells that induce natural differentiation (Zhang et 
al, 2014).  The cytokines in the media interact with cytokine receptors, which induce 
physical and genetic changes within the cell.  Differentiation via soluble factors is 
advantageous because a number of recombinant cytokines are commercially available, 
and no other cell types are necessary. 
Table 1. Cytokines and the Cell Lineage to which They Direct Stem Cell Fate (Wang et al, 2010; 
Harris et al, 2011; Faroni  et al, 2013; Stromps  et al, 2010) 
Cytokine Cell Origin Target Cell Lineage 
TGF-β1 (5ng/mL) 
BMP-4 (2.5 ng/mL) 
Heparin (7.5 U/mL) 
ADSC Smooth Muscle Cells 
(Wang et al, 2010; 
Harris et al, 2011) 
rEGF (.2 ng/mL) 
BPE (25 µg/mL) 
ADSC Urothelial Cells 
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1.4.3 Indirect and Direct Co-Culture of Stem Cells and Differentiated Cells 
An indirect co-culture of stem cells with differentiated cells utilizing a trans-well 
insert to separate the two cell types (Figure 3) has been proven effective in differentiating 
stem cells toward bone, cartilage, adipose, urothelial and muscle lineages (Zhao, 2012; 
Zhang et al, 2014).  Direct co-cultures involve culturing stem cells in direct contact with 
differentiated cells.  This methodology has been proven to effectively differentiate stem 
cells toward neuronal, smooth muscle and urothelial lineages (Zhao, 2015; Merfeld-
Clauss, 2014; Liu, 2009). 
The exact differentiation mechanism of indirect co-cultures is unknown, but it has 
been demonstrated that paracrine signaling is a large factor in the differentiation of the 
stem cells.  Cytokines released from the differentiated cells interact with cytokine 
receptors on the stem cells that induce genetic and physical changes within the stem cell 
population.  While this approach efficiently directs stem cell fate toward a specific cell 
lineage, the use of differentiated cells causes concerns regarding the attainability of 
healthy autologous cells, and the immunogenicity of stem cells differentiated with 
allogeneic cells.   
γ-aminobutyric acid 
adenosine 5′-triphosphate 
ADSC Schwann Cells (Faroni et 
al, 2013) 
TGF-β3 (10 ng/mL) 
Insulin (6.25 ng/mL) 
ADSC Chondrocytes (Stromps 
et al, 2010) 
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Like indirect co-culture, the exact mechanism of differentiation is unknown for 
direct co-cultures, but it has been shown that cell signaling and cell-contact play a role in 
the differentiation of stem cells.  In a study by Merfeld-Clauss et al, ADSCs directly co-
cultured with endothelial cells differentiated toward a SMC lineage.  The ADSCs in 
direct contact with the endothelial cells differentiated more quickly, while those further 
away differentiated to SMCs over a longer period of time.  They concluded that direct 
contact with endothelial cells will differentiate ADSCs toward a SMC lineage, and 
Figure 3. Methods of differentiation. (A) Conditioned Media where media 
from differentiated cells (yellow) is cultured with undifferentiated stem cells 
(blue), (B) Soluble Factors where chemical agents important to differentiation 
are introduced to the undifferentiated stem cell (blue) culture media, (C) Co-
culture where a differentiated cell type (yellow) is cultured with 
undifferentiated stem cells (blue), (D) Direct Co-culture where differentiated 
cells are cultured alongside undifferentiated stem cells 
A. 
B. 
C. 
D.
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factors secreted by endothelial cells will differentiate ADSCs toward a SMC lineage.  In 
another study by Liu et al, ADSCs were directly and indirectly co-cultured with 
urothelial cells and cultured in conditioned media from urothelial cells.  They found that 
only the ADSCs directly co-cultured with urothelial cells were differentiated toward a 
urothelial lineage.  Therefore, they concluded that direct cell-to-cell contact was 
responsible for the differentiation. 
1.5 Cell Seeding Techniques for Tissue Engineering Scaffolds 
Cells can be seeded onto naturally derived and acellular scaffolds in either a two-
dimensions or a three-dimensional manner.  Two dimensional cell seeding is a simpler 
methodology that results in a single layer of cells.  Three-dimensional cell seeding is a 
more intricate method and results in multiple layers of cells. 
1.5.1 Two Dimensional Cell Seeding 
Two dimensional cell seeding involves placing cells on top of a scaffold or flat 
surface and waiting for the cells to naturally attach to the surface. The cells seeded in this 
manner are not able to pile on top of one another, which results in a monolayer 
morphology which is not natural for all cell types (Antoni et al, 2015).  In addition, due 
to this monolayer structure, the cells are only in contact with cells at their periphery, and 
can only communicate and interact with those cells as well. Therefore, this cell culture 
model does not accurately model the in vivo state.  
Table 2. Description of the Models, Advantages and Limitations of 3D Cell Culture (Antoni et al, 
2015) 
Characteristics Properties 
3D Culture Models Whole animals and organotypic explant cultures 
Cell spheroids cultures 
Polarized epithelial cell cultures 
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Microcarrier cultures 
Tissue-engineered models 
Advantages Cell number monitoring 
Viability 
Morphology 
Proliferation 
Differentiation 
Response to stimuli 
Cell-cell communication 
Migration of tumor cells into surrounding tissues 
Invasion of tumor cells into surrounding tissues 
Cell polarization 
Angiogenesis stimulation 
Immune system evasion 
Drug metabolism 
Gene expression 
Protein synthesis 
General cell function 
Physiological genotype relevance 
Physiological phenotype relevance 
In vivo relevance 
Limitations Reproducibility between batches of biomimetic scaffolds 
Extraction of all cells for analysis with increased size and tortuosity 
Creation of 3D matrices 
Capacity to scale up or down a single 3D format 
Handling of post culturing processing 
Imaging depending on the scaffold size, material transparency and microscope 
depth 
Performance, sensitivity and compatibility with high-throughput screening 
instruments 
Optimization for 3D cell culturing of the assays used to determine the cellular 
response to drug interaction 
Control of culture conditions 
1.5.2 Three Dimensional Cell Seeding / Layer-by-Layer Assembly 
Naturally occurring organs present with the body are three-dimensional 
arrangements of cells with intricate cell-to-cell and cell to matrix interactions (Antoni et 
al, 2015).  Cell to matrix interactions typically involve fibronectin and collagen, and this 
matrix provides complex biochemical and physical signals (Matsusaki et al, 2012).  
These interactions affect basic biological mechanisms such as cell morphology, 
differentiation, gene expression, protein synthesis and others (Table 2).  Therefore, in 
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tissue engineering cell-seeded scaffolds, it is important to best produce in vivo relevance.  
One method by which to achieve a three-dimensional cell-seeded tissue-
engineered scaffold is by layer-by-layer assembly.  Layer-by-layer assembly is a unique 
bottom-up approach, which utilizes hierarchical cell manipulation to fabricate three-
dimensional cellular multilayers (Matsusaki et al, 2012). Specifically, the technique 
involves the alternate immersion of cells and/or scaffolds into extra-cellular matrix 
(ECM) proteins such as fibronectin and gelatin.  Fibronectin is known to be a key 
glycoprotein involved in cell attachment, migration, proliferation and differentiation 
(Matsusaki et al, 2012).  The mechanical addition of ECM proteins such as fibronectin is 
essential to creating a three-dimensional multi-layer cell culture because the necessary 
amount of ECM is not secreted onto the cell surface during culture.  Layer-by-layer 
assembly results in scaffolds and/or cells being coated in multiple layers of cell adhesive 
materials that mimic the naturally occurring extra-cellular matrix.  This allows cells to 
better attach to a scaffold, and to better form a tissue-like construct where cells lie in 
layers on top of one another.  
1.6 Cellular Infiltration of Scaffolds 
Cellular infiltration into the interior of a scaffold is of upmost importance when 
tissue-engineering three-dimensional bladder constructs.  The infiltration of cellular 
material aids in the regeneration, reconstruction and tissue formation of the bladder 
organ.  Preliminary studies indicate that proper hydrophobicity, biochemical signals and 
physical structure can promote cellular migration into the interior of a scaffold (Zhong et 
al, 2012).   
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Although cells readily divide and proliferate on the surface of electrospun 
scaffolds, their ability to infiltrate the core of the fibrous structure is severely limited due 
to the packing of sub-micron diameter fibers, which results in small pores (Baker et al, 
2010).  This may be overcome by manipulating electrospinning conditions to create 
scaffolds with micro-scale fibers and larger pores.  However, this methodology does not 
mimic the naturally occurring ECM as well as nano-scale fibers, thereby altering cell-
scaffold interactions which result in altered cell morphology and behavior (Baker et al, 
2010). 
Another method by which to induce cellular infiltration to the interior of the 
scaffold is the incorporation of ECM proteins directly in the fibrous structure.  Proteins 
that may induce cellular infiltration include gelatin, fibrinogen, fibronectin and TGF-β2 
(Ardila et al, 2015).  In a study by Adrila et al, they demonstrated that cellular infiltration 
was greatly increased when gelatin and fibrinogen were introduced to the scaffold’s 
structure.  They also determined that the addition of TGF-β2 in the appropriate amount 
(.1 ng/mL) had a similar effect on cellular infiltration. 
A co-culture of certain cell types can also have an effect on the invasiveness of 
cells into the core of a biomaterial.  Brown et al evaluated the ability of a bladder 
acellular matrix (BAM) to support the growth of porcine bladder SMCs and urothelial 
cells.  The co-culture they designed was aimed to evaluate the effect of urothelial cells on 
SMC invasiveness into the BAM (Brown et al, 2005).  When co-cultured on the same 
side of the biomaterial, it was shown that the SMC infiltration of the BAM was 
significantly increased with numerous cells observed throughout the mid-section of the 
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matrix (Brown et al, 2005).  Therefore, it can be concluded that cellular infiltration is 
significantly affected by cell-to-cell interactions.   
1.7 Dedifferentiation of Fully and Partially Differentiated Cells 
Dedifferentiation is the process by which differentiated cells are reverted to an 
earlier, more primitive phenotype caused by a change in genetic expression (Liu et al, 
2011).  In mammalian cells, differentiation has widely been viewed as an irreversible 
process.  However, studies have revealed that differentiated mammalian cells can 
undergo dedifferentiation in response to injury or when cultured under specific conditions 
(Zhang et al, 2010; Odelberg et al, 2000).  The process of dedifferentiation produces 
multi-potent self-renewing progenitor cells, which aid in the regeneration of injured 
tissue.  
1.7.1 In Vivo Dedifferentiation 
The phenomenon of in vivo dedifferentiation is often referred to as the plasticity 
of a certain cell line.  Experimental evidence of such phenomenon, particularly 
mammalian cells, has widely been scrutinized as either imperfect analytical analyses, or 
due to unrealistic and extreme physiological environments that are not physically 
possible in vivo (Shoshani & Zipori, 2015).  Many terminally differentiated mammalian 
cells, including skeletal myoblasts, Schwann cells, germ cells, skeletal myoblasts, 
melanocytes, adipocytes and pancreatic cells retain the ability to dedifferentiate in 
response to stress, particularly during instances of substantial cell loss. (Liao et al, 2015; 
Shoshani & Zipori, 2015).  Under these conditions, dedifferentiation may be one way in 
which cells attempt to minimize damage to the body and contribute to regeneration once 
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the risk has been diminished (Odelberg et al, 2000; Zhang et al, 2010; Liu et al, 2011; 
Shoshani & Zipori, 2015).   
Based on observations of dedifferentiation, it has been proposed that all 
mammalian cells retain specific molecular machinery that dictates dedifferentiation 
(Shoshani & Zipori, 2015).  This molecular machinery is referred to as “return to stem 
state” (RtSS) and functions by sensing the cells’ external environment.  If these senses 
predict cell damage, the RtSS will “turn on” and push the cell “backwards down the 
differentiation cascade, either partially or all the way back to pluripotency” (Shoshani & 
Zipori, 2015).  Dedifferentiation may also be a mechanism, which enhances and provides 
an alternative to stem cell self-renewal (Shoshani & Zipori, 2015). 
1.7.2 In Vitro Dedifferentiation 
Mammalian cells, specifically myotubes, cardiomyocytes and neuronal cells, have 
demonstrated the ability to dedifferentiate once they have been terminally differentiated 
(Odelberg et al, 2000; Zhang et al, 2010; Liu et al, 2011).  Myotubes harvested from 
mice, when exposed to growth factors such as msx1 in culture, have demonstrated to 
decrease expression of myotube proteins, such as myogen, MRF4 and MyoD (Odelberg 
et al, 2000).  These cells have also shown to undergo morphological changes in response 
to msx1 that denotes their propensity to dedifferentiate.  In contrast, cardiomyocytes 
harvested from rats spontaneously dedifferentiate and lose their characteristic 
electrophysiological properties and striations once placed in culture conditions (Zhang et 
al, 2010).  Neuronal cells, differentiated from bone marrow mesenchymal stem cells, 
have been demonstrated to dedifferentiate in culture when soluble factors introduced for 
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the purpose of differentiation are removed (Liu et al, 2011).  The dedifferentiated cells 
showed a down-regulation in the expression of neuronal proteins such as NF-M and 
MAP-2 and expressed stem cell surface markers such as CD106, CD90 and CD45 (Liu et 
al, 2011).  The dedifferentiated cells were revealed to exhibit enhanced cell survival and 
higher efficacy in neuronal differentiation (Liu et al, 2011).  The authors concluded that 
artificially differentiated cells might only be in the fetal stages of differentiation, as 
opposed to terminally differentiated.  These cells exhibited an enhanced ability to aid in 
regeneration by surviving injury and differentiating into needed phenotypes for tissue 
restoration (Liu et al, 2011). 
Through studies involving in vitro differentiation of fully and partially 
differentiated cells, it can be concluded that autocrine and paracrine signaling and the 
physiological environment surrounding cells play a key role in the process of 
dedifferentiation (Lie et al, 2011; Zhang et al, 2010).  Further in vitro study may 
determine the usefulness of partially differentiated cells. Also, additional in vitro study of 
partially differentiated cells is needed to determine what factors may contribute to the 
retention of differentiated traits.  
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Chapter 2: Research Rationale 
Over 400 million people worldwide suffer from bladder pathology including 
congenital malformations, bladder cancer and voiding dysfunctions and as many as 
50,000 people in the United States can benefit from bladder augmentation surgery 
(Adamowicz, 2013;  Oberpenning et al, 1999; Bouhout et al, 2013; Tran & Damaser, 
2015; NYU School of Medicine; BioPlan Associates, 2001).  The current gold standard 
approach for bladder augmentation replaces diseased bladder tissue with gastrointestinal 
(GI) segments, which are known to cause numerous complications including urinary tract 
infection, metabolic abnormalities, abnormal drug kinetics, secondary malignancies, 
impaired renal function and donor site morbidity (Tu et al, 2013; Vasdev et al, 2013).  
The cause of these complications is due to the fact that GI tissues naturally absorb 
specific solutes that bladder tissue is designed to excrete (Atala, 2011). 
Previous studies demonstrated that a tissue-engineered construct may be used as a 
bladder tissue replacement.  In a study by Atala et al, a PGA+collagen scaffold seeded 
with autologous smooth muscle and urothelial cells provided relief for high pressure or 
poorly compliant bladders (Atala et al, 2006).  The tissue engineered bladder biopsies 
also showed an adequate structural architecture and phenotype and no metabolic 
consequences were recorded (Atala et al, 2006).  However, in a Phase II clinical trial 
study using the same methodology to treat neurogenic bladders, adverse events were 
recorded in all patients and the results did not support the prior effectiveness of the 
tissue-engineered bladder (Joseph et al, 2014).  
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The exact reason for the failure in clinical trials is unknown.  However flaws in 
scaffold design and the use of autologous cells from diseased bladders may be a 
contributing factor to the adverse outcomes. This project aimed to establish human 
adipose derived stem cells (hADSCs) as a potential cell source, as opposed to autologous 
cells, to seed a tissue-engineered biomimetic patch to replace GI segments in bladder 
augmentations.  To explore hADSCs as a possible cell source to infiltrate a biomimetic 
bladder tissue scaffold, the present master’s thesis research consisted of the following 
four aims: 
Aim1:  To Analyze the Effectiveness of SMIM in Differentiating ADSCs to SMCs 
Rationale: Previous studies demonstrated that hADSCs have the ability to differentiate 
into SMCs (Wang et al, 2010; Harris et al, 2011; Merfeld-Clauss et al, 2014).   
Approach: The cell morphology, mRNA expression and protein expression of hADSCs 
exposed to smooth muscle inductive media (SMIM) for 10 days were examined through 
phase-contrast microscopy, RT-PCR and immunofluorescence.   
Aim 2: To Determine the Reversibility of Differentiated SMCs and Urothelial Cells 
Rationale: Dedifferentiation has been observed in both fully and partially differentiated 
cells both in vitro and in vivo (Zhang et al, 2010; Odelberg et al, 2000; Liao et al, 2015; 
Shoshani & Zipori, 2015; Liu et al, 2011).   
Approach: The cell morphology, mRNA expression and protein expression of 
differentiated SMCs and urothelial cells exposed to growth media for 7 days were 
examined through phase-contrast microscopy, RT-PCR and immunofluorescence.   
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Aim 3:  To Determine the Retention of Differentiated Traits of SMCs and Urothelial 
Cells in a Co-Culture 
Rationale: Previous studies have demonstrated that a co-culture of cell types can induce 
differentiation, and help retain differentiation (Merfeld-Clauss et al, 2014; Zhao et al, 
2012; Zhang et al, 2014; Zhao et al, 2015; Liu et al, 2009).   
Approach: The cell morphology and protein expression of SMCs and urothelial cells 
incubated in a co-culture in various types of media (Growth media, SMIM, KSFM, ½ 
SMIM – ½ KSFM) for 7 days were examined histologically.   
Aim 4:  To Evaluate the Infiltration of Differentiated SMCs into a PCUU Scaffold 
Rationale: Cellular infiltration into the interior of a scaffold is of upmost importance in 
tissue-engineered bladder constructs in the regeneration of 3D tissue structure.   
Approach: The degree of infiltration of SMCs incubated on fibronectin and gelatin coated 
PCUU scaffolds and uncoated PCUU scaffolds for 7 days were evaluated semi-
quantitatively on histological sections.  
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Chapter 3: Materials and Methods 
3.1 Cell Culture 
Human adipose derived stem cells (hADSCs, Lonza, Walkersville, MD) were 
cultured in growth medium (DMEM supplemented with 10% FBS and 1% Glutamax, 
Thermo Fisher Scientific) under standard cell culture conditions, that is, a humidified 
atmosphere at 95% air and 5% CO2 at 37°C.  Upon confluency, hADSCs were passaged 
using a trypsin solution (.25% trypsin, 2.21 mM EDTA and sodium bicarbonate solution, 
Corning).  Cells under passage number 9 were used for experimentation. 
To induce differentiation into SMCs, hADSCs were seeded at a density of 2*103 
cells / cm2 and cultured in growth medium for 24 hours and the medium was switched to 
smooth muscle inductive medium (SMIM: DMEM supplemented with 2.5 ng/mL TGF-
β1 (ProSci), 5 ng/mL PDGF-BB (ProSci)) for the next 10 days with a media change 
every 2 days. Induction of hADSCs differentiation toward a urothelial lineage was 
achieved by following a protocol previously established in the Nagatomi Lab (Turner, 
2015).  Briefly, cells were cultured in growth medium until confluent and then cultured in 
defined keratinocyte serum free media (KSFM, Thermo Fisher Scientific) for the next 14 
days with a media change every 2-3 days.  To test for dedifferentiation, the differentiation 
media (SMIM, KSFM) were switched back to growth medium. 
3.2 Immunofluorescence   
Cells cultured on chamber slides were washed with PBS and fixed using 10% 
neutral buffered formalin (NBF) for 30 minutes.  The cells were then subjected to 
29 
immunofluorescence staining using the routine protocol.  Briefly, the cells were 
incubated in a blocking solution, which minimized unspecific binding of the primary 
antibody, consisting of 2% non-fat dried milk in 50mM Tris-HCl for 30 minutes.  For 
intracellular proteins of interest, .1% Triton was added to the blocking solution to 
permeablize the membrane.  Cells were incubated with the primary antibody (Table 3) 
either overnight at 4°C or at room temperature for 2 hours.  After incubation with the 
primary antibody, the cells were incubated with the fluorescently labeled secondary 
antibody (Table 4) for 2 hours at room temperature, shielded from light. To counterstain 
the nuclei, cells were incubated with 300 nM DAPI for 5 minutes.  The cells were then 
dried in increasing concentrations of ethanol (50%, 75%, 90%, 100%) for 2 minute each, 
and mounted on a cover slip. 
3.3 Reverse Transcription Polymerase Chain Reaction  
Total RNA was isolated from cells (SMCs: 450,000; Urothelial cells: 2*106; 
hADSCs: 2*106) using the RNeasy kit (VENDOR) following the manufacturer’s 
instructions.  Briefly, cells were removed from each flask using a trypsin solution (.25% 
trypsin, 2.21 mM EDTA and sodium bicarbonate solution, Corning) and then centrifuged 
(400 rcf) to attain a cell pellet for each sample. The cell pellets were homogenized, 
transferred to RNeasy spin columns and centrifuged (400 rcf).  Following wash steps, 
RNase free water is added to the spin column and centrifuged to elute the RNA samples.  
The nucleic acid concentration was quantified (ng/ µL) using a nanodrop 
spectrophotometer (Thermo Fisher Scientific) and samples were stored at -20°C until use 
in subsequent experiments. 
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Reverse transcription was carried out with 1 µg of RNA from each sample using the 
RETROscript kit (Thermo Fisher Scientific) and following the manufacturer’s 
instructions.  Briefly, each sample was mixed with Oligo(dT) and was incubated at 85°C 
for 3 minutes for the purpose of purifying the mRNA and adding a tail of 100-300 
adenine residues.  After the cycle was completed, the samples were mixed with 10x RT 
buffer, dNTP mix, and MMLV-RT enzyme (Thermo Fisher Scientific).  The samples 
were then incubated at 44°C for 1 hour and 92°C for 10 minutes to synthesize cDNA. 
Polymerase chain reaction was performed using the QuantiTech SYBR Green PCR 
kit and the manufacturer’s instructions (Qiagen).  Each sample of cDNA (.05 µg) was 
mixed with the forward and reverse primer of interest (2 µL; 5µM; Table 5), and 2X 
SYBR Green master mix, which contains DNA polymerase, dNTPs and dUTPs.  A PCR 
protocol was used that had been previously established in the Nagatomi Lab (Turner, 
2015).  Each cycle consisted of the DNA denaturation step at 95°C followed by primer 
annealing at 55°C and primer extension at 72°C , all of which(?) were repeated for 40 
cycles. Gene expression levels of differentiated SMCs, dedifferentiated SMCs and 
dedifferentiated urothelial cells were analyzed and compared to control hADSCs, 
differentiated SMCs and differentiated urothelial cells, respectively, using the ΔΔCt 
method.   
Table 3.  Primary Antibodies Used in Immunofluorescence 
Primary Antibody Dilution Factor 
Rabbit Polyclonal Anti-αSMA  (Abcam) 1/100 
Goat Polyclonal Anti-SM-22α  (Abcam) 1/00 
Rabbit Polyclonal Anti-SM-MHC (Abcam) 1/50 
Goat Polyclonal Anti-UP1b  (SCBT) 1/200 
Goat Polyclonal Anti-CK20  (SCBT) 1/200 
Rabbit Anti-GAPDH  (SCBT) 1/100 
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Table 4. Secondary Antibodies Used in Immunofluorescence 
Secondary Antibody (Alexa Fluor® 488) Dilution Factor 
Goat Polyclonal Anti-Rabbit  (Invitrogen) 1/500 
Donkey Polyclonal Anti-Goat  (Invitrogen) 1/500 
Table 5. Primers used in RT-PCR 
mRNA encoding for Protein Primer 
CD90 5’ GAGCCTCCGTCTGGACTGC  3’ 
GAGCGGTATGTGTGCTCAGG 
CD105 5’ GCTGACTCTCCAGGCA TCC  3’ 
GCCTGGATTTGTAGGCCAAG 
UP1b 5’ TTGCTGTGGCGTAAATGGTC  3’ 
GCCTCCAGGTTGAGAGGTTC 
CK20 5’ TGGATTTCAGTCGCAGAAGC       3’ 
CATAAACGCTGGGTGTCGTC 
αSMA 5’ ACCCACAATGTC- CCCATCTA 
3’ TGATCCACA-TCTGCTGGAAG 
SM-22α 5’ ATGGCCAACAAGGGTCC 
3’ CTTCAAAGAGGTCAACAG 
SM-MHC 5’ GGACGACCTGGTTGTTGATT 
3’ GTAGCTGCTTGATGGCTTCC 
GAPDH 5’ ACCACAGTCCATGCCATCAC  3’ 
RTCCACCACCCTGTTGCTGTA 
3.4 Co-Culture of Differentiated SMCs with Differentiated Urothelial Cells 
A trans-well cell culture insert (Sigma Aldrich) was used in the co-culture of two 
different cell types to grow on either side of a polycarbonate membrane, which was 
coated with thin fibronectin and gelatin in a layer-by-layer fashion.  Briefly, the scaffold 
was incubated for 15 minutes in alternating solutions of fibronectin (FN, .04 mg/mL, 
Sigma Aldrich) and gelatin (G, .04 mg/mL, VWR), with washing steps of 50 mM Tris-
HCl (pH= 7.4) in between, until the scaffold was covered in a total of 9 layers.  
The differentiated SMCs and urothelial cells (see 2.1 Cell Culture) were 
individually coated with thin fibronectin and gelatin layers in a layer-by-layer fashion 
following a protocol similar to that for coating the membrane.  Briefly, following 
32 
centrifugation (400 rcf) the cell pellet was re-suspended and incubated in the FN solution 
for 1 minute, centrifuged (400 rcf) for 2 minutes and the supernatant was discarded. This 
process was repeated with Tris-HCl to wash the cells and then a G coating was applied 
until a total of 9 layers were present on the surface of the cells. 
The coated SMCs were suspended in SMIM and 200,000 cells were seeded onto 
the bottom of each insert and were incubated upside-down for 2 hours.  The inserts were 
placed right-side up in the well-plate and immersed in SMIM for 24 hours.  After the 24 
hours incubation period, the urothelial cells (200,000) were then seeded on the top in a 
specific media type: Growth media, SMIM, KSFM and ½ SMIM – ½ KSFM. Each co-
culture group was incubated for 7 days with a media change every 2-3 days. 
3.4.1 Hematoxylin and Eosin Staining and Immunofluorescence 
At the end of the prescribed time periods, the cells on the inserts were fixed in 
10% NBF for 1 hour and then incubated in 30% sucrose at 4°C overnight.  The 
membranes carrying the cells were then embedded in OCT (Optimal Cutting 
Temperature), cryosectioned and stained.  For H&E staining, after immersing in distilled 
water the sections were stained with hematoxylin for 1 minute and excess was rinsed off 
with distilled water. The samples were then dipped in a bluing reagent and washed in 
distilled water.  This was followed by immersion in eosin for 20 seconds.  The sections 
were then dried in different solutions of alcohol (95%, 100%) and cover slipped for 
preservation.  Immunostaining of the co-culture scaffolds that had been cryosectioned 
were performed according to a protocol similar to that for cells cultured on glass slides 
(See 2.2 Immunofluorescence) with appropriate primary and secondary antibodies 
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(Tables 3 and 4). 
3.5 Infiltration of Differentiated SMCs into PCUU Scaffold 
PCUU scaffolds were donated to the Nagatomi Lab by Dr. William Wagner 
(McGowan Institute of Regenerative Medicine, University of Pittsburg) and were 
prepared using conventional electrospinning methods.  Briefly, PCUU dissolved in HFIP 
(12 wt%) and cell culture media (DMEM, 10% FBS, 5% penicillin/streptomyocin)  was 
fed at .98-1.2 mL/hr using two syringe pumps (Havard Apparatus PhD) located 17 and 
4.5 cm from the target mandrel (Sivaraman, 2015).  High voltage was utilized to charge 
the PCUU solution at 12 kV and the target at -7 kV).  Electrospinning was performed at 
~200 rpm with a 5 cm motor translation pattern for 2 hours.   
The original membranes of trans-well inserts were mechanically removed, and 
PCUU scaffolds were attached to each insert using a sterile rubber band (Figure 4).  The 
PCUU scaffolds were either coated in a single layer of FN or 9 FN- G layers.  The 
differentiated SMCs were seeded onto the PCUU scaffolds at a density of 1*106 cells/cm2 
Figure 4. PCUU-Cell Culture Insert. PCUU scaffold attached to 
trans-well insert using a sterile rubber-band 
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and cultured in SMIM for up to 7 days. After 1, 3, and 7 days, the cells were fixed and 
stained with hematoxylin and eosin (See 2.4.1 Hematoxylin and Eosin Staining and 
Immunofluorescence).  Semi-quantitative analysis was performed which included 
determining the maximum infiltration depth, average infiltration depth and the 
distribution of cellular infiltration. 
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Chapter 4: Results 
4.1 SMC Differentiation 
Phase contrast imaging revealed that the undifferentiated hADCSs exhibited an 
elongated morphology with multiple long cell extensions (Figure 5A, Table 6).  In 
contrast, after 10 days in SMIM, the cells shift towards a fusiform shape more indicative 
of smooth muscle (Figure 5B, Table 6).  RT-PCR results provided evidence that hADSCs 
cultured in SMIM for 10 days, when compared to undifferentiated hADSCs cultured in 
growth medium, demonstrated increased average mRNA expression for αSMA, SM-22α 
and SM-MHC 938-, 309- and 74- fold, respectively (Figure 6).  Expression for CD90 and 
CD105 was decreased to 0.3% of undifferentiated cells.  Immunofluorescence images 
further demonstrated differentiation of hADSCs into SMCs (Figure 7).  SMC phenotypic 
marker proteins αSMA and SM-22α were present in both undifferentiated and 
differentiated cells (Figure 7B, C, F, G).  However, SM-MHC was present in only the 
hADSCs cultured in SMIM for 10 days (Figure 7H). 
Figure 5. Phase Contrast Imaging of ADSCs and Differentiated SMCs.  Undifferentiated hADSCs 
(A) exhibit an elongated morphology with long cell extensions.  In contrast, differentiated SMCs (B)
exhibit a more fusiform morphology with less cellular extensions.  After 10 days incubation in SMIM,
ADSC morphology appears to shift towards SMC-like cells  Scale bars are 200 µm.
A) B) 
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Figure 6. Relative Expression Ratios of mRNA Markers in Differentiated SMCs. 
mRNA expression in ADSCs incubated in SMIM for 10 days was normalized to the 
expression in undifferentiated ADSCs cultured in growth medium.  Error bars indicate ± 2 
S.D.
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4.2 SMC and Urothelial Cell Dedifferentiation 
To determine whether SMC and urothelial cell differentiation are terminal, the 
growth factors were removed from the culture media and phenotypic markers, namely,  
cell morphology, mRNA expression and protein expression were examined. 
Phase contrast imaging revealed that undifferentiated hADSCs 24 hours after seeding 
exhibited an elongated morphology with long extensions typical of hADSCs (Figure 8A, 
D; Table 6).  After 14 days in KSFM, the stem cells shift towards a more cobblestone 
morphology, typical of urothelial cells (Figure 8B, Table 6).  After 10 days in SMIM, the 
hADSCs shift towards a more fusiform morphology indicative of SMCs (Figure 8E;  
A) GAPDH B) αSMA C) SM-22α D) SM-MHC 
E) GAPDH F) αSMA G) SM-22α H) SM-MHC 
I) GAPDH J) αSMA K) SM-22α L) SM-MHC 
Figure 7. Immunofluorescence Images of ADSCs, Differentiated SMCs and Dedifferentiated SMCs. 
ADSCs in growth medium (A-E), ADSCs cultured in SMIM for 10 days (E-H) and differentiated SMCs 
cultured in growth media for 7 days.  Green fluorescence is indicative of SMC proteins (αSMA, SM-22α, 
SM-MHC) Blue fluorescence is indicative of nucleic material.  Scale bars are 200 µm. 
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Table 6).  When these differentiated urothelial cells and SMCs were cultured in non-
inductive growth media for 7 days, both cell types reverted to an elongated morphology 
typical of hADSCs (Figure 8C, F). 
RT- PCR was used to further verify the differentiated state of both urothelial cells 
and SMCs normalized to the levels of differentiated cells.  In SMCs, mRNA expression 
for αSMA, SM-22α and SM-MHC was decreased to 9.3%, 3.0% and 1.5% of the 
differentiated cells, respectively.  Expression of CD90 and CD105 was increased by 2.24 
and 8.41 fold, respectively (Figure 9).  In urothelial cells 9.84 and 32.4 fold increased 
expression was observed for CD90 and CD015, respectively and mRNA expression for 
ADSC SMC 
Average Number of Extensions 5.09* 2.65* 
ADSC Urothelial Cell 
Average Area (mm2) .06126** .01538** 
A B C 
D E F 
Figure 8. Phase Contrast Images of ADSCs Under Media Conditions.  ADSCs cultured in 
growth medium (A,D), ADSCs cultured in KSFM for 14 days (B), ADSCs cultured in SMIM for 
10 days, differentiated urothelial cells and SMCs cultured in growth media for 7 days (C,F).  Scale 
bars are 200 µm 
Table 6. Average Number of Extensions of ADSCs and Differentiated SMCs and Average Area of 
ADSCs and Differentiated Urothelial Cells 
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UP1b was decreased to .01% of the differentiated cells, and CK20 was unchanged.  
Moreover, immunofluorescence was used to determine the presence of phenotypic 
markers at the protein level in hADSCs, differentiated SMCs and urothelial cells, and 
dedifferentiated SMCs and urothelial cells (Figures 7 and 10). SMCs retained αSMA and 
SM-22α proteins, but expression of SM-MHC was lost after 7 days of culture in growth 
media without the growth factor supplements (Figure 7I-L).  Urothelial cells retained the 
protein CK20, but expression of UP1b was lost after switching differentiation media to 
growth media (Figure 10G- I). 
4.3. Co-culture of Differentiated SMCs and Urothelial Cells 
SMCs and urothelial cells were co-cultured on either side of a culture insert 
membrane to determine the effect of each cell type on retention of differentiated traits of 
the other cell type.  In gross observations of the inserts, it was seen that urothelial cells 
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Figure 9. Relative Expression Ratios of mRNA Markers in Dedifferentiated SMCs and 
Dedifferentiated Urothelial Cells.  mRNA expression in differentiated urothelial cells and SMCs 
incubated in growth media for 7 days was normalized to the expression in differentiated SMCs and 
urothelial cells Error bars indicate ± 2 S.D.    
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Figure 10. Immunofluorescence Images of ADSCs Differentiated Urothelial Cells and 
Dedifferentiated Urothelial Cells.  Undifferentiated ADSCs cultured in growth medium (A-
C), ADSCs cultured in KSFM for 14 days (D-F), differentiated urothelial cells cultured in 
growth media for 7 days (G-I). Green fluorescence is indicative of urothelial proteins (UP1b, 
CK20).  Blue fluorescence is indicative of nucleic material.  Scale bars are 200 µm. 
A) GAPDH B) CK20 C) UP1b
E) CK20
H) CK20 I) UP1bG) GAPDH
D) GAPDH F) UP1b
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aggregated in all groups except for those cultured in growth media after 7 days (Figure 
11A).  H&E stained histological sections exhibited that co-cultured urothelial cells and 
SMCs in growth medium (Figure 12A) retained a monolayer on either side of the 
scaffold.  Urothelial cells and SMCs cultured in SMIM (Figure 12B) and KSFM (Figure 
 12C) exhibited aggregation of urothelial cells and no attachment of SMCs.  However, 
when urothelial cells and SMCs were co-cultured in a ½ SMIM and ½ KSFM blend 
media (Figure 12D, E) aggregation of urothelial cells on one side was observed, but  
 SMCs retained a monolayer of on the other side of the membrane.   
Immunofluorescence images of the co-cultures in growth media demonstrated 
positive staining for CK20, αSMA and SM-22α, but UP1b and SM-MHC were absent 
(Figure 13). Similarly, in ½ KSFM – ½ SMIM (Figure 14) SMCs (A-F) expressed CK20, 
αSMA and SM-22α, but not UP1b and SM-MHC.  The urothelial cells in the ½ KSFM – 
½ SMIM (Figure 14G-L) co-culture showed positive staining for CK20 and αSMA, but 
not UP1b, SM-22α and SM-MHC.  
4.4 Infiltration of Differentiated SMCs into PCUU Scaffold 
Figure 11. Gross Morphology of Urothelial Cells Incubated on Trans-Well Membrane Cell 
Culture Inserts.  Differentiated urothelial cells and SMCs in a co-culuture incubated in non-indctive 
media (A), SMIM (B), KSFM (C) and ½ SMIM – ½ KSFM blend media.  Red arrows designate areas 
of urothelial cell accumulation 
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SMCs were cultured on FN-G coated and uncoated PCUU scaffolds for 1, 3 and 7 
days and the amount of cellular infiltration was determined.  H&E stained histological 
sections exhibited a layer of cells on top of the uncoated scaffold after 1 and 3 days 
(Figure 15A,B), which became sparse after 7 days (Figure 15C).  Cells infiltrating the 
uncoated scaffold were observed after 1, 3 and 7 days, but to a limited extent (Figure 17  
A B C 
D E 
Figure 12. H&E Images of Co-Cultured Differentiated SMCs and Urothelial Cells.  
Differentiated SMCs and urothelail cells co-cultured in growth media (A), SMIM (B), KSFM 
(C) and ½  SMIM – ½ KSFM blend media.  Urothelial cells are present on the left side of the
scaffold and SMCs on the right.  Scale bars are 200 µm.
43 
C) CK20 A) GAPDH
F) SM-MHC 
B) UP1b 
D) αSMA E) SM22 
Figure 13.  Immunofluorescence of Co-Cultured Differentiated SMCs and Urothelial Cells 
Incubated in Growth Medium.  Differentiated SMCs and urothelial cells co-cultured in growth 
media for 7 days. Green fluorescence is indicative of SMC proteins (αSMA, SM-22α, SM-MHC) or 
urothelial proteins (UP1b, CK20).  Blue fluorescence is indicative of nucleic material.  Scale bars are 
200 µm. 
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Figure 14. Immunofluorescence of Co-Cultured Differentiated SMCs and Urothelial Cells 
Incubated in ½ KSFM – ½ SMIM Blend Media.  Differentiated SMCs and urothelial cells co-
cultured in ½ KSFM – ½ SMIM blend media for 7 days. Green fluorescence is indicative of SMC 
proteins (αSMA, SM-22α, SM-MHC) or urothelial proteins (UP1b, CK20).  Blue fluorescence is 
indicative of nucleic material.  Blue fluorescence is indicative of nucleic material.  Scale bars are 200 
µm. 
D) αSMA 
B) CK20A) GAPDH
F) SM-MHCE) SM-22
C) UP1b
J) αSMA 
H) CK20G) GAPDH
L) SM-MHCK) SM22
I) UP1b
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A-C). On the FN-G coated scaffold, SMCs formed a multilayer, with few cells infiltrating
the interior after 1 day (Figure 15D; Figure 17D).  In contrast, SMCs formed an 
aggregate on top of the coated scaffold, but many other cells infiltrated toward the center 
after 3 days (Figure 15E; Figure 17E).  Most of the SMCs infiltrated toward the center of 
the coated scaffold at 7 days (Figure 15F; Figure 17F).  The amount of cellular 
infiltration of coated and uncoated scaffolds was also semi-quantitatively analyzed by 
measuring individual cell movement into the scaffold (Table 7).  Cellular infiltration on 
the uncoated scaffold was similar between the 1, 3 and 7 day groups (Table 7; Figure 
A) B) C) 
D) E) F) 
1 Day 3 Days 7 Days 
Uncoated Average 
(µm) 
26.07* 25.08 24.74** 
Maximum 
(µm) 
109.06 94.47 179.6 
Coated Average 
(µm) 
22.64* 25.33 38.11** 
Maximum 
(µm) 
122.0 144.7 171.3 
Figure 15. H&E Images of SMCs Cultured on PCUU Scaffolds 100x.  Differentiated SMCs 
cultured on uncoated PCUU scaffolds (A-C) and FN-G coated scaffolds (D-F) for 7 days.  Scale bars 
are 200 µm. 
Table 7. Average and Maximum Infiltrative Depth of Differentiated SMCs Cultured on Coated 
and Uncoated PCUU Scaffolds  
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16A). When compared to the coated scaffold, SMC infiltration of the uncoated scaffold 
was significantly greater after 1 day (Table 7). The amount of cellular infiltration 
between coated and uncoated scaffolds was similar after 3 days.  However, cellular 
infiltration of the coated scaffold was significantly greater than that of the uncoated 
scaffold after 7 days (Table 7).  In addition, after 7 days, SMCs infiltrated to a greater 
degree when compared to 1 and 3 days, and to all uncoated groups (Figure 16).  
47 
0	
10	
20	
30	
40	
50	
60	
70	
0-25	 25-50	 50-75	 75-100	 100-175	
Pe
rc
en
ta
ge
 o
f C
el
ls
 (%
) 
Infiltrative Depth (µm) 
Uncoated	Scaffolds	
Day	1	
Day	3	
Day	7	
A) 
0	
10	
20	
30	
40	
50	
60	
70	
80	
0-25	 25-50	 50-75	 75-100	 100-175	
Pe
rc
en
ta
ge
 o
f C
el
ls
 (%
) 
Infiltrative Depth (µm) 
Coated Scaffolds 
Day	1	
Day	3	
Day	7	
B) 
Figure 16.  Distribution of Differentiated SMC Infiltration into Uncoated and Coated PCUU 
Scaffolds.  Individual SMC movement into uncoated and FN-G coated PCUU scaffolds was 
measured. 
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35 µm   
160 µm   
A) B) C) 
D) E) F) 
Figure 17. H&E Images of Differentiated SMCs Cultured on PCUU Scaffolds 400x.  Differentiated 
SMCs cultured on uncoated PCUU scaffolds (A-C) and FN-G coated scaffolds (D-F) for 7 days.  Bars 
within scaffold indicate 25 µm depths into the scaffold.  Scale bars are 50 µm. 
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Chapter 5: Discussion 
A number of previous in vitro studies have shown that different media conditions 
impact cell morphology, genetic transcription and protein expression of ADSCs (Tiang et 
al, 2010; Zhang et al, 2014; Lee et al, 2015; Faroni et al, 2013; Stromps et al, 2014; 
Wang et al, 2014; Harris et al, 2011; Zhao, 2015).  Other studies have shown that, along 
with media conditions, biomechanical signaling from cell-to-cell contact also influences 
stem cell differentiation (Merfeld-Clauss et al, 2014; Liu, 2009).  Based these studies, it 
was hypothesized that factors within the cellular environment, such as soluble factors and 
cell-to-cell contact, are important stimuli for attaining and retaining differentiated traits.  
For this reason, ADSCs, differentiated SMCs and differentiated urothelial cells were 
cultured in varying media conditions. Moreover, differentiated SMCs and differentiated 
urothelial cells were co-cultured, and the cellular responses of each cell type were 
observed.  
5.1 SMC Differentiation 
Results of the present study demonstrate changes indicative of a shift towards a 
contractile SMC phenotype in cellular morphology when ADSCs were cultured in SMIM 
for 10 days.  Specifically, about 90% of the differentiated SMCs exhibited a more 
spindle-like morphology with less cellular extensions compared to ADSCs.  This was 
consistent with previous reports of a phenotypic shift from ADSCs toward a contractile 
SMC phenotype (Wang et al, 2010; Harris et al, 2011).  In addition, SMC mRNA 
expression of αSMA, SM-22α and SM-MHC was greater in the differentiated cells than 
ADSCs and exhibited a more quantitative indication that SMIM stimulated SMC 
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differentiation (Figure 6).  SMC positive protein expression of αSMA, SM-22α and SM-
MHC after differentiation also indicated differentiation toward a contractile SMC 
phenotype. Out of the phenotypic markers examined, αSMA is the most highly conserved 
among various cell types, including pluripotent stem cells and fibroblasts, and is only an 
early indication of SMC differentiation (Harris et al, 2009; Lao et al, 2016).  In contrast, 
SM-22α is only conserved amongst pluripotent stem cells, including ADSCs, and SMCs 
and is therefore an intermediate indicator of SMC differentiation (Harris et al, 2009).  
Finally, SM-MHC is only expressed in contractile SMCs, and is therefore a specific 
indicator of advanced SMC differentiation (Harris et al, 2009). The results of the present 
study are in agreement with previous studies that exposed human ADSCs to soluble 
factors in media to induce differentiation into a SMC phenotype.  For example, Wang et 
al. reported that culturing ADSCs cultured with TGF-β1 (5 ng/mL) and BMP-4 (2.5 
ng/mL) resulted in a shift towards a SMC genotype and phenotype (Wang et al, 2010).  
However, Wang et al used twice as much TGF-β1 than was used in the present study and 
successfully differentiated ADSCs toward a contractile SMC phenotype in 7 days.  In a 
separate study by Harris et al, ADSCs were differentiated into SMCs by culturing with 
angiotensin II (1µM), sphingosylphosphorylcholine (2 µM)  or TGF-β1 (2 ng/mL) (Harris 
et al, 2011).   Harris et al used less TGF- β1, but it took 3 weeks to successfully 
differentiate ADSCs into SMCs.  The results of the present study indicate that ADSC 
differentiation into SMCs can be achieved using a lesser quantity of soluble factors and in 
a shorter time period when compared to other reports, which reduces overall costs of cell 
preparation. 
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Although there are a multitude of methodologies to obtain cells needed for tissue 
engineering (Mahfouz et al, 2013; Tran & Damaser, 2015; Takahashi & Yamanaka, 
2006; Kim et al, 2014; de Villiers et al, 2009), due to the lack of healthy autologous cells 
in a diseased bladder, differentiation techniques requiring co-cultures and conditioned 
media with autologous cells is not a plausible approach (Jack et al, 2009, Mahfouz et al, 
2013). Exposing stem cells to soluble factors, however, is a faster approach to 
differentiate ADSCs into SMCs.  While ADSCs can be differentiated into SMCs under 
SMIM in less than 3 weeks, it can require up to 6 weeks to expand autologous cells to 
acquire the necessary amount of cells for seeding a scaffold (Mahfouz et al, 2013).  
Harvesting smooth muscle and urothelial tissue from the body also includes an invasive 
surgical procedure, which introduces risk to the patient.  Differentiation using soluble 
factors, however, has been shown to only partially differentiate cells, and once the 
soluble factors are removed the cells revert back to a more primitive phenotype (Liu et al, 
2011).   
5.2 SMC and Urothelial Cell Dedifferentiation 
After ADSCs were differentiated into SMCs and urothelial cells in the induction 
media (SMIM and KSFM, respectively), their ability to retain their phenotypic traits was 
inspected. Results of the present study indicate that ADSC differentiation toward SMC 
and urothelial lineages were partial and they reverted to a stem cell-like cell once the 
soluble factors were removed.  There was a shift in cell morphology toward that of an 
ADSC in response to the removal of soluble factors (Figure 8).  Expression of markers at 
both the mRNA and protein level also suggests a shift away from the differentiated 
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phenotype (Figure 9, 10).  These results were similar to those of previous studies that also 
reported dedifferentiation when soluble factors were removed (Liu et al, 2011).  In a 
study by Liu et al, bone marrow stem cells were differentiated toward a neuronal lineage 
under a neuronal induction medium containing DMEM and soluble factors (2% dimethyl 
sulfoxide, 200 µM butylated hydroxyanisole, 25 mM potassium chloride, 2mM valporic 
acid, 10 µM forskolin, 1 µM hydrocortisone and 5 µg/ mL insulin), and subsequently 
dedifferentiated by culturing in media without the soluble factors.  Although these 
dedifferentiated cells expressed stem cell characteristics, they exhibited a reprogrammed 
phenotype different from the original stem cell population (Liu et al, 2011).  Moreover, 
after dedifferentiation the cells demonstrated enhanced cell survival and higher efficacy 
in neuronal differentiation when compared to unmanipulated stem cells. (Liu et al, 2011). 
Together with the previous findings of Liu et al, it can be speculated that the 
dedifferentiated cells in the present study are distinctly different from their original 
ADSC population and that they may also exhibit a higher efficacy in differentiating 
toward SMC and urothelial cells.  This is further supported by the retention of CK20 in 
dedifferentiated urothelial cells (Figure 9,10).  Finally, these dedifferentiated cells might 
also exhibit increased cell survival, which may be useful for enduring the body’s 
inflammatory response when implanted for tissue-engineering purposes. 
5.3 Co-culture of Differentiated SMCs and Urothelial Cells 
The present study also aimed to determine the ability of differentiated SMCs and 
urothelial cells to retain their phenotypic traits in co-cultures with various media 
conditions.  After incubation for 7 days, aggregation of urothelial cells was seen in all 
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induction media groups (SMIM, KSFM, ½ SMIM- ½ KSFM) but not in growth medium 
(DMEM, 10% FBS, 1% Glutamax).  The results of the present study were similar to 
those of a previous study in our laboratory.  Briefly, differentiated urothelial cells (8*106 
cells/ well) in KSFM were seeded onto trans-well cell culture inserts to explore the 
feasibility of developing a multilayer urothelial tissue (Turner, 2015).  After 24 hours, 
however, all of the urothelial cells aggregated, which was visible under gross 
examination and H&E staining (Turner, 2015).  One of the possible reasons for the 
aggregation of the urothelial cells is that the induction media (SMIM, KSFM, ½ SMIM – 
½ KSFM) lacked FBS, which contains multiple soluble factors that enhance cell 
adhesion, including vitronectin.  In a study by Hayman et al, vitronectin was shown to 
increase adhesion of bovine corneal endothelial cell adhesion by 8-16 fold when 
compared to fibronectin (Hayman et al, 1985; Underwood & Bennett, 1989).  The 
presence of vitronectin and other factors in FBS could explain the absence of urothelial 
cell aggregation in the group cultured in serum-containing growth medium.   
In previous studies, indirect co-cultures of autologous cells (adipocytes, 
chondrocytes, osteoblasts and urothelial cells) and stem cells have been proven to be an 
effective method in differentiating stem cells toward a certain lineage (Zhao et al, 2015; 
Zhang et al, 2014).  It is widely believed that autocrine and paracrine signaling are 
responsible for this differentiation.  Therefore, it was hypothesized that two types of 
differentiated cells (SMCs and urothelial cells) would release cytokines and aid in the 
retention of phenotypic traits.  However, after incubation in an indirect co-culture for 7 
days, only protein expression of αSMA, SM-22α and CK20 were retained and expression 
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SM-MHC and UP1b were lost.  These results are identical to SMCs and urothelial cells 
incubated in growth medium separately, meaning that the co-culture did not support the 
retention of differentiated traits.  The cells in the present study were only partially 
differentiated; therefore, it can be hypothesized that they do not release the same 
biochemical signals as fully differentiated SMCs and urothelial cells, which would lead 
to a difference in cellular response. Moreover, it can be speculated that cell-to-cell 
contact is an important factor, although chemical signaling does play a role in 
differentiation and retention of differentiated traits.  Previously, it was found that only 
ADSCs co-cultured directly with urothelial cells differentiated into urothelial cells, but 
not ADSCs co-cultured indirectly (Liu et al, 2009).  In another study, ADSCs closest to 
endothelial cells in a direct co-culture differentiated toward a SMC lineage more quickly 
than those further away (Merfeld-Clauss et al, 2014).  Therefore, it can be concluded that 
both soluble factors and cell-to-cell contact in the cellular microenvironment are of 
upmost importance when determining differentiation and retention of differentiated traits.   
5.4 Infiltration of Differentiated SMCs into PCUU scaffold  
The present study examined the effects of layer-by-layer fibronectin (FN) and 
gelatin (G) coating of a PCUU scaffold on SMC infiltration.  The results indicate that the 
presence of the ECM proteins on a PCUU scaffold increases the effectiveness of SMC 
infiltration into a PCUU scaffold.  These results are in agreement with previous studies 
that have demonstrated the effect of proteins on cellular infiltration into a scaffold.  A 
study by Ardila et al demonstrated that the presence of TGF-β2 (.1 ng/mL) greatly 
increased the amount of infiltration of autologous SMCs into an electrospun membrane 
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when compared to cells cultured on the electrospun membrane without TGF-β2 (Ardila et 
al, 2015).  Additionally, in a study by Uchida et al, PCUU scaffolds were alternately 
immersed in FN and G to create thickness-controlled nanolayers (Uchida et al, 2015).  
This nano-layer formation is based on non-specific physical adsorption of FN onto the 
polymer and its subsequent interactions with G (Uchida et al, 2015).  The presence of G 
allows FN to infiltrate the interior space of the fibrous PCUU, without G it was 
discovered that FN accumulated on the surface of the scaffold (Uchida et al, 2015).  The 
presence of FN and G was also shown to aid in cellular adhesion to the scaffold, and in 
cellular infiltration into the interior of the scaffold (Uchida et al, 2015).  This was likely 
due to the cell-binding domain present on FN, which aids in cellular attachment 
(Matusaki et al, 2012).    
The greater degree of SMC adhesion on the coated scaffolds when compared to 
the uncoated scaffolds after 1 day was likely due to the presence of FN and G multilayers 
(Figure 16; Figure 17).  FN provided cellular adhesion sites both on the surface and 
within the fibrous interior of the scaffold, which likely supported SMC adhesion.  
Additionally, Uchida et al determined that cells actively migrate toward a scaffold with 
FN-G coating (Uchida et al, 2015).  The increased infiltration of SMCs into the coated 
scaffold when compared to the uncoated scaffold after 7 days was likely attributed to 
SMCs affinity for the FN-G coating present within the interior of the scaffold.     
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Chapter 6: Conclusions and Recommendations 
In the present study, culturing ADSCs in SMIM was proven to be an effective 
method in differentiating toward a SMC lineage. However, differentiated SMCs and 
urothelial cells dedifferentiated once factors important to differentiation were removed.   
Co-culturing of differentiated SMCs and urothelial cells did not support retention of 
differentiated traits either. Taken together, these in vitro results indicate that cells 
differentiated via soluble factors within the media only achieve partial differentiation.  
When the differentiated SMCs were seeded on a PCUU scaffold, layer-by-layer coating 
with fibronectin and gelatin enhanced the infiltration into the scaffold.  This is likely due 
to the adsorption of fibronectin to the scaffold and subsequent interaction with gelatin 
provides cellular adhesion sites both within and on the surface of the scaffold.  Future 
study recommendations include: 
• To explore the effect of a direct co-culture of differentiated SMCs and
urothelial cells on the retention of differentiated traits.
o Rationale: Biomechanical signaling through cell-to-cell contact is
an important factor in the process of differentiation, and may lead
to the retention of differentiated traits.
• To investigate the effect of layer-by-layer coating of both a PCUU
scaffold and SMCs on cellular infiltration into the scaffold.
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o Rationale: Layer-by-layer coating of the cells will increase cell-to-
matrix interactions and possibly eliminate the accumulation of
SMCs on the PCUU scaffold.
• To explore the effects of soluble factors incorporated into the PCUU
electrospun membrane.
o Rationale: The presence of soluble factors has a direct effect on
the retention of differentiated traits and incorporation of these
factors would lead to paracrine signaling after the inductive media
has been removed.
• To investigate the cellular changes in differentiated SMCs and urothelial
cells after dedifferentiation in regards to cell survival and efficacy in
differentiation.
o Rationale:  In the present study, only the process of
dedifferentiation is explored, and not the positive effect
dedifferentiation may have on the cells.
• To explore the effects of cyclic strain on the effectiveness of SMC
infiltration into a PCUU scaffold and on the retention of differentiated
traits.
o Rationale: The present study only investigates static scaffolds
seeded with SMCs and cyclic strain will intermittently increase
porosity of the scaffold.  SMCs within the body also undergo
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constant cyclic strain, which is an environmental condition that can 
affect the retention of differentiated traits. 
• To investigate the effects of layer-by-layer coating a PCUU electrospun
scaffold with alternating layers of fibronectin, vitronectin and gelatin on
SMC infiltration
o Rationale: The present study only investigates the effects of
fibronectin on cellular adhesion.  Vitronectin also greatly enhances
cellular adhesion and may aid in cellular infiltration as well.
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